Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma.

Details

Ressource 1Download: 35028526.pdf (495.90 [Ko])
State: Public
Version: Final published version
License: CC BY 4.0
Serval ID
serval:BIB_0C13AAC5EB9D
Type
Article: article from journal or magazin.
Publication sub-type
Letter (letter): Communication to the publisher.
Collection
Publications
Institution
UNIL/CHUV
Title
Prolonged Remissions After Nivolumab Plus Gemcitabine/Oxaliplatin in Relapsed/Refractory T-cell Lymphoma.
Journal
HemaSphere
Author(s)
Houot R., Poeschel V., Altmann B., Angel S., Thurner L., Illmer T., Andre M., Dreyling M., Maisonneuve H., Tilly H., Mayer S., Casasnovas O., Le Gouill S., Offner F., Cartron G., Kerkhoff A., Weber T., Hoffmann J., Ziepert M., Klapper W., Itti E., Hellwig D., Natchkebia G., de Leval L., Rosenwald A., Haioun C., Dercle L., Gaulard P., Held G.
ISSN
2572-9241 (Electronic)
ISSN-L
2572-9241
Publication state
Published
Issued date
02/2022
Peer-reviewed
Oui
Volume
6
Number
2
Pages
e672
Language
english
Notes
Publication types: Journal Article
Publication Status: epublish
URN
urn:nbn:ch:serval-BIB_0C13AAC5EB9D2
OAI-PMH
oai:serval.unil.ch:BIB_0C13AAC5EB9D
DOI
10.1097/HS9.0000000000000672
Pubmed
35028526
Web of science
000748357900001
Open Access
Yes
Create date
17/01/2022 8:34
Last modification date
15/06/2022 6:08
Usage data